Oppenheimer Lowers Bioceres Crop Solutions (NASDAQ:BIOX) Price Target to $6.00

Bioceres Crop Solutions (NASDAQ:BIOX - Free Report) had its price target lowered by Oppenheimer from $7.00 to $6.00 in a report published on Tuesday,Benzinga reports. The brokerage currently has an outperform rating on the stock.

Separately, Wall Street Zen raised shares of Bioceres Crop Solutions from a "sell" rating to a "hold" rating in a research note on Saturday, June 21st. One analyst has rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat, the company currently has a consensus rating of "Buy" and an average target price of $8.38.

Bioceres Crop Solutions Trading Down 1.6%

Shares of Bioceres Crop Solutions stock traded down $0.06 during trading on Tuesday, reaching $3.75. 153,670 shares of the company were exchanged, compared to its average volume of 183,595. The business has a 50-day moving average price of $4.63 and a 200-day moving average price of $4.97. The firm has a market capitalization of $235.16 million, a price-to-earnings ratio of -26.78, a P/E/G ratio of 1.10 and a beta of 0.41. The company has a quick ratio of 0.74, a current ratio of 1.02 and a debt-to-equity ratio of 0.22. Bioceres Crop Solutions has a twelve month low of $3.51 and a twelve month high of $11.78.

Bioceres Crop Solutions (NASDAQ:BIOX - Get Free Report) last posted its earnings results on Wednesday, May 21st. The company reported ($0.02) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.10) by $0.08. The company had revenue of $59.60 million during the quarter, compared to analyst estimates of $61.80 million. Bioceres Crop Solutions had a negative return on equity of 2.37% and a negative net margin of 2.14%. Sell-side analysts anticipate that Bioceres Crop Solutions will post -0.05 EPS for the current fiscal year.

Hedge Funds Weigh In On Bioceres Crop Solutions

Institutional investors have recently modified their holdings of the business. JPMorgan Chase & Co. lifted its position in Bioceres Crop Solutions by 17.0% in the 4th quarter. JPMorgan Chase & Co. now owns 105,301 shares of the company's stock valued at $640,000 after acquiring an additional 15,328 shares in the last quarter. Ballast Asset Management LP lifted its holdings in shares of Bioceres Crop Solutions by 23.5% in the fourth quarter. Ballast Asset Management LP now owns 431,887 shares of the company's stock valued at $2,620,000 after purchasing an additional 82,187 shares in the last quarter. Jump Financial LLC bought a new stake in shares of Bioceres Crop Solutions in the fourth quarter valued at about $72,000. Stifel Financial Corp boosted its position in shares of Bioceres Crop Solutions by 51.9% during the fourth quarter. Stifel Financial Corp now owns 61,958 shares of the company's stock worth $377,000 after buying an additional 21,168 shares during the period. Finally, Long Focus Capital Management LLC grew its holdings in shares of Bioceres Crop Solutions by 130.7% during the fourth quarter. Long Focus Capital Management LLC now owns 744,748 shares of the company's stock worth $4,528,000 after buying an additional 421,931 shares in the last quarter. Institutional investors own 17.68% of the company's stock.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.